Takanori Takebe and Hideki Taniguchi at Yokohama City University showed the generation of vascularised and functional human liver from human induced pluripotent stem cells (hiPSCs) by transplantation of in vitro grown liver buds (rudimentary liver).
The study demonstrates a proof-of-concept that organ bud transplantation offers an alternative approach for treating organ failure by generating a 3D and vascularised organ.
During the early liver organogenesis, liver progenitor cells delaminate from the foregut endodermal sheet and form a three-dimensional liver bud (LB), a condensed tissue mass that is soon vascularised.
"These observations led us to hypothesise that three-dimensional (3D) liver bud formation can be mimicked in vitro by culturing hepatic endoderm cells with endothelial and mesenchymal lineages," researchers said
"Here, we found that, although cells were plated on 2D conditions, hiPSC-derived liver progenitos organised into macroscopically visible 3D liver bud (hiPSC-LBs, or "rudimentary liver") by cultivating with human endothelial cells and human mesenchymal cells, presumably mimicking the above stated early developmental interactions," they said.
Surprisingly, researchers observed a formation of developing endothelial networks along with homogenously distributed hiPSC-liver progenitors even in vitro.
Transplantation of hiPSC-LBs resulted in a formation of functional human vasculatures by connecting to the host vessels just within 48 hours.
The formation of functional vasculatures stimulated the maturation of hiPSC-LBs into tissue resembling the adult liver with multiple liver-specific functions such as protein production and human-specific drug metabolism.
Furthermore, mesenteric transplantation of hiPSC-LBs rescued the drug-induced lethal liver failure model.
"Thus, to our knowledge, we firstly demonstrated that the generation of functional human organ from pluripotent stem cells," researchers said.
"Our study demonstrates a proof-of-concept that "organ bud transplantation" offers an alternative approach resulting in the generation of a 3D, vascularised organ.
The study was published in the journal Nature.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
